In a comprehensive analysis of the entire cancer genome, the gene KLRB1 encoding CD161 showed a good clinical prognosis in breast, colorectal, prostate, melanoma, and neuroblastoma carcinomas (28–32). This evidence concerns the gene KLRB1 and cancer.